February 2012 Drug Update Information - Pharmacy Benefits ...
February 2012 Drug Update Information - Pharmacy Benefits ...
February 2012 Drug Update Information - Pharmacy Benefits ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
500 mg extended release, 500 count (NDC 00378-0352-05) - discontinued<br />
Metformin tablets, Ranbaxy<br />
500 mg, 100 count (NDC 63304-0860-01) - discontinued<br />
d<br />
500 mg, 500 count (NDC 63304-0860-05) - discontinued<br />
d<br />
750 mg, 100 count (NDC 63304-0767-01) - discontinued<br />
d<br />
Metformin tablets, Sandoz<br />
500 mg, 12 x 60 package (NDC 00781-5050<br />
-61)<br />
850 mg, 12 x 60 package (NDC 00781-5051<br />
-61)<br />
1000 mg, 12 x 60 package (NDC<br />
00781-5052-61)<br />
Metformin tablets, Teva<br />
500 mg, 100 count, unit dose (NDC 00093-1048-93) - discontinued<br />
850 mg, 100 count, unit dose (NDC 00093-1049-93) - discontinued<br />
1000 mg, 100 count, unit dose (NDC 00093-7214-93) - discontinuedd<br />
Metformin tablets, UDL<br />
850 mg, 100 count, unit-dose (NDC 51079-0973-20) - discontinued<br />
500 mg, 25 count, unit-dose (NDC 51079-0972-19) - discontinued<br />
500 mg, 100 count, unit-dose (NDC 51079-0972-20) - discontinued<br />
500 mg, 300 count, unit-dose (NDC 51079-0972-56) - discontinued<br />
Metformin tablets, Watson<br />
850 mg, 1000 count (NDC 62037-0675-10) - discontinued<br />
1000 mg, 1000 count<br />
(NDC 62037-0676-10)<br />
- discontinued<br />
Reason for the Shortage<br />
Mylan, UDL, and Teva could not provide a reason for the shortage.<br />
Apotex has metformin products unavailable due to an FDA import ban.<br />
Sandoz has metformin products on shortage due to manufacturing delays.<br />
Ranbaxy<br />
has all discontinued metformin oral<br />
tablets.<br />
Mutual discontinued<br />
all metformin products.<br />
Teva discontinued metformin unit dose presentations in early-August, 2011.<br />
UDL discontinued metformin 500 mg 100 unit dose presentation in late-July, 2011.<br />
Watson discontinued<br />
d metformin 850 mg and<br />
1000 mg presentations.<br />
.<br />
Article link: http://www.ashp.org/<strong>Drug</strong>Shortages/Current/Bulletin.aspx?id=731<br />
Source: http://www.a<br />
ashp.org<br />
Lorazepam injectable presentations<br />
<strong>February</strong><br />
3, <strong>2012</strong><br />
Products Affected - Description<br />
Lorazepam 2 mg/mL, Akorn<br />
1 mL vial (NDC 17478-0040-01)<br />
Lorazepam 2 mg/mL, Bedford<br />
1 mL vial (NDC 55390-0168-10)<br />
- discontinued<br />
10 mL vial (NDC 55390-0170-10) - discontinued<br />
Lorazepam 4 mg/mL, Bedford<br />
1 mL vial (NDC 53390-0169-10)<br />
- discontinued<br />
10 mL vial (NDC 53390-0171-10) - discontinued<br />
Lorazepam 2 mg/mL, Hospira<br />
1 mL iSecure prefilled syringes (NDC 00409-1985-05) - discontinued<br />
1 mL Carpuject syringes (NDC 00409-1985-<br />
-30)<br />
1 mL vial (NDC 00409-6778-02)<br />
10 mL vials (NDC 00409-6780-02)<br />
Lorazepam 4 mg/mL, Hospira<br />
51